CF PharmTech, Inc engages in the research, development, production and sale of respiratory diseases pharmaceutical products. The company is headquartered in Suzhou, Jiangsu and currently employs 574 full-time employees. The company went IPO on 2025-10-08. The Company’s product portfolio primarily focused on respiratory diseases, including asthma, chronic obstructive pulmonary disease (COPD) and allergic rhinitis. The firm's primary products include CF017, a budesonide suspension for inhalation targeting bronchial asthma, and CF018, an azelastine hydrochloride and fluticasone propionate nasal spray approved for allergic rhinitis. The firm mainly conducts its business in the domestic market.
02652.HK stock price ended at $0 on Mardi, after dropping NaN%
On the latest trading day Feb 17, 2026, the stock price of 02652.HK fell by NaN%, dropping from $NaN to $NaN. During the session, the stock saw a volatility of NaN%, with prices oscillating between a daily low of $NaN and a high of $NaN. On the latest trading day, the trading volume for 02652.HK decreased by -- shares, aligning with the declining prices, which may indicate weakening market confidence in the near term. In total, -- shares were traded, with a market value of approximately --.
Signaux Techniques de 02652.HK
Résumé des Signaux Techniques
Acheter des signaux 0
Signaux neutres 7
Signaux de vente 0
Strong Sell
Sell
Neutral
Buy
Strong Buy
02652.HK présente actuellement 0 signaux d'achat et 0 signaux de vente. L'action est en Tendance baissière depuis --, avec une variation totale du prix de -- pendant cette période. En général, les indicateurs techniques indiquent une tendance Neutral à moyen terme.
Signaux haussiers/baissiers pour 02652.HK
Nous analysons les indicateurs clés comme les moyennes mobiles, le RSI, le MACD et le volume de transactions pour générer des signaux haussiers et baissiers pour 02652.HK, vous aidant à prendre des décisions d'investissement éclairées.